Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | XBP1 | P17861 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ACP1 | P24666 | 1/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.45 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.44 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3787230 | 0.96 | L3MBTL1 (0.53) | L3MBTL1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL9630497 | 0.87 | GRM4 (0.49) | L3MBTL1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL11656945 | 0.84 | SMN1; SMN2 (0.60) | MEN1KMT2AMAPTSMN1; SMN2HPGD | |
| SCHEMBL6200925 | 0.83 | MEN1 (0.51) | L3MBTL1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL2095413 | 0.81 | MEN1 (0.49) | L3MBTL1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL9358296 | 0.80 | HPGD (0.71) | L3MBTL1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL10950808 | 0.80 | KDM4E (0.60) | L3MBTL1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL1188370 | 0.80 | HPGD (0.71) | MEN1KMT2AMAPTSMN1; SMN2HPGD | |
| SCHEMBL5879121 | 0.80 | L3MBTL1 (0.47) | L3MBTL1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL31153302 | 0.79 | MAPT (0.53) | MEN1KMT2AMAPTSMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4183096-B1 | KEY EXCHANGE PROTOCOL | ARQIT LTD (GB) | 2025-12-17 | — | — | EP | claimed |
| CN-119497111-A | Intelligent communication switching method based on artificial intelligence | 合肥枫梵科技有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119114040-B | Preparation method and application of bionic phospholipid membrane monolithic column for screening and separating antimicrobial peptides | 佛山大学 | 2025-02-14 | — | — | CN | claimed |
| CN-119114040-A | Preparation method and application of bionic phospholipid membrane monolithic column for screening and separating antimicrobial peptides | 佛山大学 | 2024-12-13 | — | — | CN | claimed |
| CN-118759187-A | Application of group of biomarkers in prostate cancer molecular typing and prognosis evaluation | 上海交通大学医学院附属新华医院 | 2024-10-11 | — | — | CN | claimed |
| US-20230299949-A1 | KEY EXCHANGE PROTOCOL | Arqit Limited (GB) | 2023-09-21 | — | — | US | claimed |
| EP-4183096-A1 | KEY EXCHANGE PROTOCOL | Arqit Limited (GB) | 2023-05-24 | — | — | EP | claimed |
| WO-2022018432-A1 | KEY EXCHANGE PROTOCOL | Arqit Limited (GB) | 2022-01-27 | — | — | WO | claimed |
| EP-0239508-A2 | 2-Cyano-benzimidazole derivatives, their preparation and use as fungicides, their association with other fungicides | RHONE-POULENC AGROCHIMIE (FR) | 1987-09-30 | — | — | EP | claimed |
| JP-57091906-A | — | — | None | — | — | JP | disclosed |
| EP-4704371-A1 | DIGITAL CERTIFICATE | Bundesdruckerei GmbH (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-20260010259-A1 | TOUCH-CONTROL MODULE, DISPLAY APPARATUS, AND TOUCH-CONTROL DRIVING METHOD | CHENGDU BOE OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2026-01-08 | — | — | US | disclosed |
| US-20250370547-A1 | METHOD FOR INTERACTING WITH A VIRTUAL OBJECT, PROGRAM USING SAME, AND IMMERSIVE REALITY DEVICE | ORANGE (FR) | 2025-12-04 | — | — | US | disclosed |
| US-20250374547-A1 | INTEGRATED CIRCUIT, VERIFICATION SYSTEM INCLUDING THE SAME, AND OPERATING METHOD OF THE VERIFICATION SYSTEM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-12-04 | — | — | US | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
| EP-0239508-A2 | 2-Cyano-benzimidazole derivatives, their preparation and use as fungicides, their association with other fungicides | RHONE-POULENC AGROCHIMIE (FR) | 1987-09-30 | — | — | EP | disclosed |
| US-4501756-A | CONTROLS THE GROWTH OF DRUG-RESISTANT STRAINS OF FUNGI | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-02-26 | — | — | US | disclosed |
| JP-S5791906-A | ANTIFUNGAL COMPOSITION FOR AGRICULTURAL AND HORTICULTURAL PURPOSE | SUMITOMO CHEM CO LTD | 1982-06-08 | — | — | JP | disclosed |
| EP-0051871-A1 | N-Phenylcarbamate derivatives, process for their preparation, fungicidal compositions and a method for controlling fungi | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-05-19 | — | — | EP | disclosed |
| US-4220787-A | BY REACTING THE CORRESPONDING CARBAMATE WITH A 2-HYDROXYCARBOXYLIC ACID ESTER | BASF AKTIENGESELLSCHAFT (DE) | 1980-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260010259-A1 | TOUCH-CONTROL MODULE, DISPLAY APPARATUS, AND TOUCH-CONTROL DRIVING METHOD | TYRO3, TTL, TLN1 | L3MBTL1 1782/4885MEN1 2277/4885KMT2A 4421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.